Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsWith over a decade of experience in phage display technology, Creative Biolabs can provide a series of antibody or peptide libraries that are available for licensing or direct screening. These ready-to-use libraries are invaluable resources for isolating target-specific binders for various research, diagnostic or therapeutic applications. Highlights
Creative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
HighlightsAn important step in biotherapeutics engineering is to characterize and group (e.g. bin) a library of monoclonal antibodies generated against a specific antigen by their epitope binding regions. Scientists from Creative Biolabs have proved that the use of the IBIS MX96 system in conjunction with the CFM (Continuous Flow Microspotter) offers enhanced productivity in antibody binning.
The IBIS MX96 & CFM combination enables high throughput epitope binning with capacity of 96 antibodies directly from less than 200 µL supernatant of each clone, minimizing sample consumption and overcoming throughput limitations and/or labeling restrictions of current methods. This “epitope binning” platform enables the maintenance of epitope diversity and provides important information to broaden intellectual property protection.
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
